Literature DB >> 12588188

Molecular characterization of mitomycin C-induced large deletions and tandem-base substitutions in the bone marrow of gpt delta transgenic mice.

Akira Takeiri1, Masayuki Mishima, Kenji Tanaka, Akihumi Shioda, Otoya Ueda, Hiroshi Suzuki, Makoto Inoue, Ken-ichi Masumura, Takehiko Nohmi.   

Abstract

Deletion mutations constitute an important class of mutations that may result in a variety of human diseases, including cancer. Although many chemicals and ionizing radiations induce deletions, this class of mutation has been poorly characterized at the molecular level, particularly in vivo. Here we report the molecular nature of deletions as well as base substitutions induced by antitumor antibiotic mitomycin C (MMC) in the bone marrow using a novel transgenic mouse, gpt delta. In this mouse model, deletions and point mutations in lambda DNA integrated in the chromosome are individually selected as Spi(-) (sensitive to P2 interference) phages and 6-thioguanine-resistant bacterial colonies, respectively. The mice were treated with MMC (1 mg/kg/day) for five consecutive days. One week after the last treatment, lambda phage was rescued from the genomic DNA of the bone marrow by in vitro packaging reactions and subjected to Spi(-) and 6-thioguanine selections. The mutant frequency of Spi(-) with large deletions increased more than 20-fold over that of the control. Molecular sizes of the large deletions were mostly more than 2,000 base pairs. The large deletions frequently occurred between two short direct repeat sequences from 2 to 6 base pairs, suggesting that they are generated during the end-joining repair of double-strand breaks induced by interstrand cross-links in DNA. In 6-thioguanine selection, tandem-base substitutions, such as 5'-GG-3' to 5'-AT-3', were induced. It highlights the relevance of intrastrand cross-links as genotoxic lesions. Previous in vitro studies report the induction of single-base substitutions and single-base deletions by MMC. However, no such mutations were identified in vivo. Thus, our results strongly caution that in vitro mutation spectra do not necessarily reflect genotoxic events in vivo and emphasize the importance of transgenic rodent genotoxicity assays to examine the roles of DNA adducts in mutagenesis and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12588188     DOI: 10.1021/tx0255673

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  5 in total

1.  Integration of in vivo genotoxicity and short-term carcinogenicity assays using F344 gpt delta transgenic rats: in vivo mutagenicity of 2,4-diaminotoluene and 2,6-diaminotoluene structural isomers.

Authors:  Naomi Toyoda-Hokaiwado; Tomoki Inoue; Kenichi Masumura; Hiroyuki Hayashi; Yuji Kawamura; Yasushi Kurata; Makiko Takamune; Masami Yamada; Hisakazu Sanada; Takashi Umemura; Akiyoshi Nishikawa; Takehiko Nohmi
Journal:  Toxicol Sci       Date:  2009-12-21       Impact factor: 4.849

2.  The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks.

Authors:  Laura J Niedernhofer; Hanny Odijk; Magda Budzowska; Ellen van Drunen; Alex Maas; Arjan F Theil; Jan de Wit; N G J Jaspers; H Berna Beverloo; Jan H J Hoeijmakers; Roland Kanaar
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

3.  Genomic integration of lambda EG10 transgene in gpt delta transgenic rodents.

Authors:  Kenichi Masumura; Yasuteru Sakamoto; Wakako Kumita; Masamitsu Honma; Akiyoshi Nishikawa; Takehiko Nohmi
Journal:  Genes Environ       Date:  2015-12-01

4.  Genome-Wide Mutational Signature of the Chemotherapeutic Agent Mitomycin C in Caenorhabditis elegans.

Authors:  Annie S Tam; Jeffrey S C Chu; Ann M Rose
Journal:  G3 (Bethesda)       Date:  2015-11-12       Impact factor: 3.154

5.  Effects of the scid mutation on X-ray-induced deletions in the brain and spleen of gpt delta mice.

Authors:  Kenichi Masumura; Fumio Yatagai; Masako Ochiai; Hitoshi Nakagama; Takehiko Nohmi
Journal:  Genes Environ       Date:  2020-05-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.